Transcatheter Mitral Valve Replacement with the Medtronic Intrepid TMVR System in patients with severe symptomatic mitral regurgitation APOLLO Trial

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Mitral Regurgitation
  • Age: Between 18 Year(s) - 110 Year(s)
  • Gender: Male or Female
  • Other Inclusion Criteria:
    1. Subjects have moderate to severe or severe symptomatic mitral regurgitation
    2. Heart Team agrees that patient is a candidate for bioprosthetic mitral valve replacement
    3. Subject and the treating physician agree that the subject

You may not be eligible for this study if the following are true:

  • Randomized Cohorts
    1. Subject has comorbidities such that the Heart Team agrees predicted risk of operative mortality is <3% at 30 days or has =35% risk of mortality or irreversible major morbidity at 30 days
    2. Estimated life expectancy o


If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.